Multi-organ Transit Time Acquisition Using Contrast Ultrasound

Active, not recruiting

• Conditions: Healthy
• Interventions: Drug: Definity Suspension for Injection

• Registration Number: NCT05135169
• Lead Sponsor: Vanderbilt University Medical Center

Brief Summary

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-11-02
• Study First Submitted QC: 2021-11-23
• Study First Posted: 2021-11-26
• Study Start: 2022-03-03
• Primary Completion: 2023-06-16
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-12
• Last Update Posted: 2024-07-16
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• at least 18 years old
• able to give informed consent

Exclusion Criteria

1. Known allergic reaction to Definity ultrasound contrast
2. Pregnancy/Nursing - as assessed/disclosed by the participant

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Contrast administration	Definity Suspension for Injection	-

Primary Outcome Measures

Name	Time	Method
transit time	during procedure	time it takes for contrast to traverse an organ

Trial Locations

Locations (1)

VUMC; 🇺🇸 Nashville, Tennessee, United States